Compare Puri Global Sukses Tbk. (PURI) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Puri Global Sukses Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Puri Global Sukses Tbk. trades at Rp159 (market cap 162B, 9.39M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Puri Global Sukses Tbk. is the larger of the two by market cap. Which is the better fit depends on your goals.
| PURI | SCPI | |
|---|---|---|
Market Cap | 162B | 104.4B |
Volume | 9.39M | — |
Lot | 93.89K | — |
Turnover | 1.5B | — |
Average Price | 160.21 | — |
Value | 1.5B | — |
Indicative Equilibrium Price | 159 | — |
Indicative Equilibrium Volume | 1.44K | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Puri Global Sukses Tbk.
PT Puri Global Sukses Tbk (Company) was established in Batam based on notarial deed No. 19 dated January 20, 2016 of Bun Hai, S.H.,M.Kn. The Company has carried out its activitiescommercially in 2017.
Read more on PURI →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
